Beijing Sanfo Outdoor Products (002780)

Search documents
三夫户外(002780) - 关于控股股东、实际控制人为公司向银行申请授信额度提供担保暨关联交易的公告
2025-07-28 10:00
运动·快乐·梦想 证券代码:002780 证券简称:三夫户外 公告编号:2025-046 北京三夫户外用品股份有限公司 关于控股股东、实际控制人为公司向银行申请授信额度提供担保 暨关联交易的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、 误导性陈述或重大遗漏。 一、 担保情况概述 北京三夫户外用品股份有限公司(以下简称"公司")于 2025 年 7 月 28 日召开第五届董 事会第十六次会议、第五届监事会第十六次会议,审议通过了《关于控股股东、实际控制人 为公司向银行申请授信额度提供担保暨关联交易的议案》。因日常经营需要,公司拟向宁波银 行股份有限公司北京分行申请授信额度 3,000 万元,授信期限 1 年,年化利率为不超过 3.5%。 公司控股股东、实际控制人张恒先生及其配偶就前述授信向宁波银行股份有限公司北京分行 提供个人无限连带责任保证担保,该担保不向公司收取任何担保费用,也不需要公司提供反担 保。公司授权总经理张恒先生代表公司签署与本次授信相关的所有合同、协议及文件。协议 具体内容以公司与宁波银行股份有限公司北京分行签订的最终协议为准。 根据《深圳证券交易所股票上市规则 ...
三夫户外(002780) - 关于担保进展暨关联交易的公告
2025-07-28 10:00
运动·快乐·梦想 证券代码:002780 证券简称:三夫户外 公告编号:2025-047 北京三夫户外用品股份有限公司 关于担保进展暨关联交易的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、 误导性陈述或重大遗漏。 一、 担保情况概述 北京三夫户外用品股份有限公司(以下简称"公司")分别于 2025 年 4 月 24 日、2025 年 5 月 16 日召开第五届董事会第十四次会议、2024 年度股东大会,审议通过了《关于公司 2025 年度对外担保额度预计的议案》,同意公司对合并报表范围内的子公司向银行等金融机 构进行融资需求时提供连带责任保证担保,担保总额度为 9,500 万元人民币。额度有效期为 自 2024 年度股东大会审议通过之日起至 2025 年度股东大会召开之日止。授权公司可以根据 实际情况,在上述额度范围内,在符合要求的担保对象之间进行担保额度的调剂。担保情况 如下表: | 担保方 | 被担保方 | 担保方持股比例 | 被担保方最 | 审议批准 | 担保额度占上 | 是否关联 | | --- | --- | --- | --- | --- | --- | --- ...
三夫户外(002780) - 关于召开2025年第四次临时股东大会的通知
2025-07-28 10:00
运动·快乐·梦想 证券代码:002780 证券简称:三夫户外 公告编号:2025-049 北京三夫户外用品股份有限公司 关于召开 2025 年第四次临时股东大会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、 误导性陈述或重大遗漏。 一、召开会议的基本情况 通过深圳证券交易所交易系统进行网络投票的具体时间为:2025 年 8 月 13 日上午 09:15~09:25、09:30~11:30,下午 13:00~15:00; 通过深圳证券交易所互联网投票系统进行投票的具体时间为:2025 年 8 月 13 日上午 09:15 至下午 15:00 期间的任意时间。 2025 年 8 月 6 日下午收市时在中国证券登记结算有限公司深圳分公司登记在册的公 司全体普通股股东均有权出席股东大会,并可以以书面形式委托代理人出席会议和参加 表决,该股东代理人不必是本公司股东(授权委托书模板详见附件 3)。 第 1 页 共 6 页 1、 股东大会届次:2025 年第四次临时股东大会 2、 股东大会的召集人:公司董事会 3、 会议召开的合法、合规性:本次股东大会会议召开符合有关法律、行政法规、部门规 ...
三夫户外(002780) - 第五届监事会第十六次会议决议公告
2025-07-28 10:00
北京三夫户外用品股份有限公司(以下简称"公司")于 2025 年 7 月 22 日以电子邮件方 式向全体监事发出召开第五届监事会第十六次会议通知,会议于 2025 年 7 月 28 日以现场结 合通讯方式召开。会议由监事会主席李继娟主持,应出席监事 3 名,实际出席监事 3 名,其 中徐晓燕女士、许瑞燕女士以通讯方式参会。公司高级管理人员列席了会议。会议的召集和 召开符合《中华人民共和国公司法》和《北京三夫户外用品股份有限公司章程》的有关规定。 证券代码:002780 证券简称:三夫户外 公告编号:2025-045 北京三夫户外用品股份有限公司 第五届监事会第十六次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、 误导性陈述或重大遗漏。 运动·快乐·梦想 一、 监事会会议召开情况 二、 监事会会议审议情况 (一) 以 3 票同意,0 票反对,0 票弃权,一致通过《关于控股股东、实际控制人为公 司向银行申请授信额度提供担保暨关联交易的议案》 经审核,监事会认为:公司控股股东、实际控制人为公司向银行申请授信额度提供担保 暨关联交易事项的程序符合有关法律、法规的规定,不存在损害 ...
三夫户外(002780) - 第五届董事会第十六次会议决议公告
2025-07-28 10:00
证券代码:002780 证券简称:三夫户外 公告编号:2025-044 运动·快乐·梦想 北京三夫户外用品股份有限公司 第五届董事会第十六次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、 误导性陈述或重大遗漏。 一、 董事会会议召开情况 北京三夫户外用品股份有限公司(以下简称"公司")于2025年7月22日以电子邮件方式 向全体董事发出召开第五届董事会第十六次会议通知,会议于2025年7月28日以现场结合通讯 方式召开,会议由董事长张恒主持,应出席董事7名,实际出席董事7名,其中张恒先生、孙 雷先生、朱冰女士以现场方式参加会议,其他董事均以通讯方式参加会议。公司监事、高级 管理人员列席了会议。会议的召集和召开符合《中华人民共和国公司法》和《北京三夫户外 用品股份有限公司章程》的有关规定,会议合法、有效。 二、 董事会会议审议情况 (一) 以6票同意,0票反对,0票弃权,一致通过《关于控股股东、实际控制人为公司 向银行申请授信额度提供担保暨关联交易的议案》,关联董事张恒回避表决 经审核,董事会认为:公司控股股东、实际控制人为公司向银行申请授信额度提供担保 暨关联交易事项, ...
中小盘周报:看好AI+应用,关注膳食营养补充剂-20250727
KAIYUAN SECURITIES· 2025-07-27 14:09
AI and Market Trends - AI applications are entering a rapid growth phase, supported by mature infrastructure and decreasing costs of large model calls, enhancing commercial potential[3] - China possesses significant data reserves and a broad demand scale, providing a competitive advantage for AI development[3] Market Performance - The A-share market experienced a general rise, with the Shanghai Composite Index up by 1.67% and the Shenzhen Component Index up by 2.33% during the week[15] - Mid-cap indices such as the CSI 500 and CSI 1000 outperformed large-cap indices, with increases of 3.28% and 2.38% respectively[17] Dietary Supplements Industry - The global dietary supplement market is projected to reach $223 billion by 2026, driven by population growth and increasing health awareness[5] - HMB, a key nutrient for muscle health, is expected to see global production reach 3,572 tons by 2030, indicating strong market potential[5] Investment Recommendations - Recommended stocks include Toris (拓尔思), which has a robust open-source intelligence data resource, and Songlin Technology (松霖科技), focusing on health robots[3] - Other notable mentions are Rongxin Culture (荣信文化), which is expanding into AI+ education scenarios[3] Corporate Actions - This week, two companies listed on the A-share market, with C Shanda and C Jiyuan seeing first-day gains of 356% and 274% respectively[33] - There were six new public offerings announced, with an average discount rate of 18.9% and an average return of 40.7% on recent fundraising projects[34][40]
7月24日晚间重要公告一览
Xi Niu Cai Jing· 2025-07-24 10:25
Group 1 - Leshan Electric achieved operating revenue of 1.623 billion yuan, a year-on-year increase of 1.94%, and a net profit of 7.9031 million yuan, a year-on-year decrease of 14.55% [1] - Zhimingda reported operating revenue of 295 million yuan, a year-on-year increase of 84.83%, and a net profit of 38.3 million yuan, a year-on-year increase of 2147.93% [2] - Dahu Co. reported operating revenue of 426 million yuan, a year-on-year decrease of 14.40%, and a net loss of 2.5716 million yuan, an improvement from a loss of 13.7824 million yuan in the same period last year [3] - Yubang Electric expects a net profit of 21.2 million to 25 million yuan, a year-on-year decrease of 35.47% to 45.28% [4] - Zhejiang Securities achieved operating revenue of 6.512 billion yuan, a year-on-year decrease of 18.60%, and a net profit of 1.149 billion yuan, a year-on-year increase of 46.54% [5] - Huashu Media reported operating revenue of 4.435 billion yuan, a year-on-year increase of 2.07%, and a net profit of 254 million yuan, a year-on-year increase of 4.63% [7] Group 2 - Sinopec reported oil and gas equivalent production of 262.81 million barrels, a year-on-year increase of 2%, and crude oil processing volume of 119.97 million tons, a year-on-year decrease of 5.3% [8] - Hengrui Medicine's subsidiary received approval for clinical trials of HRS8179, aimed at reducing brain edema after stroke [8] - Hengrui Medicine's subsidiary also received approval for clinical trials of HRS-1893, intended for treating heart failure with preserved ejection fraction [8] - Wanfu Co. announced a plan to reduce its stake by up to 2% through block trading [10] - Biological Co. received a warning letter from the Inner Mongolia Securities Regulatory Bureau for inaccuracies in financial reporting [11] - Zhujiang Co. reported a signed construction area of 47.1432 million square meters across 396 projects [13] Group 3 - Watson Bio received a patent for a peptide delivery system for RNA drugs [15] - Sanwei Chemical signed 31 new contracts worth 335 million yuan in the second quarter [17] - Shenzhou Cell's SCT640C injection received approval for clinical trials for rheumatoid arthritis [18] - Xinjiang Jiaojian reported new contracts worth 1.434 billion yuan in the second quarter [19] - Lais Information plans to use 550 million yuan of idle funds for cash management [21] - Zhongqi New Materials signed a mining rights transfer contract, increasing production capacity [22] Group 4 - Hengtong Optic-Electric won multiple marine energy projects worth 1.509 billion yuan [24] - China State Construction signed new contracts totaling 2.501 trillion yuan in the first half of the year [26] - David Medical's ventilator product registration application has been accepted [28] - Tianhai Defense's subsidiary signed a construction contract worth 16.224 million yuan [29] - Nantian Information plans to sign a procurement framework contract worth 58.27 million yuan with its controlling shareholder [31] - Baida Group announced a plan to reduce its stake by up to 3% [32] Group 5 - Jinli Permanent Magnet plans to issue $117.5 million in convertible bonds [34] - Haizheng Pharmaceutical's fumarate bedaquiline raw material drug application has been approved [36] - Huatai passed the advanced intelligent factory re-evaluation in Anhui Province [37] - Everbright Bank's shareholder increased its stake from 7.08% to 8% [40] - Supor reported total operating revenue of 11.478 billion yuan, a year-on-year increase of 4.68%, and a net profit of 940 million yuan, a year-on-year decrease of 0.07% [41] - Qianjin Pharmaceutical's subsidiaries received registration certificates for two drugs [42]
三夫户外(002780) - 关于申请向特定对象发行股票获得中国证券监督管理委员会同意注册批复的公告
2025-07-23 10:47
运动·快乐·梦想 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、 误导性陈述或重大遗漏。 证券代码:002780 证券简称:三夫户外 公告编号:2025-043 北京三夫户外用品股份有限公司 关于申请向特定对象发行股票获得中国证券监督管理委员会 北京三夫户外用品股份有限公司(以下简称"公司")于 2025 年 7 月 23 日收到中国证 券监督管理委员会(以下简称"中国证监会")出具的《关于同意北京三夫户外用品股份有 限公司向特定对象发行股票注册的批复》(证监许可〔2025〕1510 号),批复主要内容如下: "一、同意你公司向特定对象发行股票的注册申请。 二、你公司本次发行应严格按照报送深圳证券交易所的申报文件和发行方案实施。 三、本批复自同意注册之日起 12 个月内有效。 同意注册批复的公告 公司董事会将按照有关法律法规和上述批复文件的要求及公司股东大会的授权,在规定 期限内办理本次向特定对象发行股票的相关事宜,并根据进展情况及时履行信息披露义务。 敬请广大投资者注意投资风险。 特此公告。 北京三夫户外用品股份有限公司董事会 二〇二五年七月二十四日 第 1 页 共 1 页 四、自 ...
三夫户外(002780) - 北京三夫户外用品股份有限公司向特定对象发行A股股票募集说明书(注册稿)
2025-07-23 10:47
股票简称:三夫户外 股票简称:002780 北京三夫户外用品股份有限公司 (Beijing Sanfo Outdoor Products Co., Ltd) (北京市昌平区陈家营西路 3 号院 23 号楼) 向特定对象发行 A 股股票 募集说明书 保荐机构(主承销商) (北京市西城区闹市口大街 9 号院 1 号楼) 二〇二五年六月 根据《证券法》的规定,证券依法发行后,发行人经营与收益的变化,由发 行人自行负责,由此变化引致的投资风险,由投资者自行负责。投资者如有任何 疑问,应咨询自己的股票经纪人、律师、专业会计师或其他专业顾问。 1-1-1 北京三夫户外用品股份有限公司向特定对象发行股票 募集说明书 (注册稿) 北京三夫户外用品股份有限公司向特定对象发行股票 募集说明书 声 明 公司及全体董事、监事、高级管理人员承诺本募集说明书不存在任何虚假记 载、误导性陈述或重大遗漏,并对其真实性、准确性、完整性承担相应的法律责 任。 公司负责人、主管会计工作负责人及会计机构负责人保证本募集说明书中财 务会计报告真实、准确、完整。 证券监督管理机构及其他政府部门对本次发行所作的任何决定,均不表明其 对发行人所发行证券的价 ...
三夫户外(002780) - 2025 Q2 - 季度业绩预告
2025-07-14 09:35
[Current Period Performance Forecast](index=1&type=section&id=%E4%B8%80%E3%80%81%E6%9C%AC%E6%9C%9F%E4%B8%9A%E7%BB%A9%E9%A2%84%E8%AE%A1%E6%83%85%E5%86%B5) The company expects a year-on-year increase in H1 2025 performance, with net profit attributable to shareholders projected to be RMB 13.5 million to RMB 20 million, a 65.14% to 144.65% increase; net profit after non-recurring items is expected to be RMB 12 million to RMB 18 million, a 230.78% to 396.16% increase Performance Forecast Comparison | Indicator | Current Period (2025 H1) | Prior Period (2024 H1) | Year-on-Year Growth | | :--- | :--- | :--- | :--- | | **Net Profit Attributable to Shareholders** | Profit: 13.5 - 20 Million RMB | Profit: 8.1748 Million RMB | 65.14% - 144.65% | | **Net Profit After Non-Recurring Items** | Profit: 12 - 18 Million RMB | Profit: 3.6278 Million RMB | 230.78% - 396.16% | | **Basic Earnings Per Share** | Profit: 0.0857 - 0.1269 RMB/share | Profit: 0.0519 RMB/share | N/A | - The performance forecast period is from January 1, 2025, to June 30, 2025, indicating a **year-on-year increase**[8](index=8&type=chunk) [Communication with Accounting Firm](index=1&type=section&id=%E4%BA%8C%E3%80%81%E4%B8%8E%E4%BC%9A%E8%AE%A1%E5%B8%88%E4%BA%8B%E5%8A%A1%E6%89%80%E6%B2%9F%E9%80%9A%E6%83%85%E5%86%B5) The financial data in this performance forecast is a preliminary estimate by the company's finance department and has not been audited by an accounting firm - The financial data in this performance forecast has **not been audited** by an accounting firm[4](index=4&type=chunk) [Explanation of Performance Changes](index=1&type=section&id=%E4%B8%89%E3%80%81%E4%B8%9A%E7%BB%A9%E5%8F%98%E5%8A%A8%E5%8E%9F%E5%9B%A0%E8%AF%B4%E6%98%8E) Performance growth is primarily attributed to the company's strategy of focusing on 'proprietary brands + national exclusive agency brands' and achieving positive results through multi-channel synergistic development, with core brands like X-BIONIC and several exclusive agency brands showing strong sales performance, significantly enhancing profitability and driving net profit growth - The company focuses on a development strategy of **'proprietary brands + national exclusive agency brands'** and achieves **synergistic development through multiple channels** including offline, e-commerce, live streaming, and wholesale[5](index=5&type=chunk) - Sports technology brand **X-BIONIC operating revenue continues to grow**, while exclusive agency brands such as **CRISPI, HOUDINI, and MYSTERY RANCH** have also achieved **strong sales performance**, serving as key drivers for **enhanced profitability** and **year-on-year net profit growth**[5](index=5&type=chunk) [Risk Warning](index=1&type=section&id=%E5%9B%9B%E3%80%81%E9%A3%8E%E9%99%A9%E6%8F%90%E7%A4%BA) The company advises that this performance forecast is a preliminary estimate, and the final financial data will be subject to the official disclosure in the '2025 Semi-Annual Report', urging investors to make cautious decisions and be aware of investment risks - This performance forecast is a **preliminary estimate** by the company's finance department, and the specific financial data should refer to the company's disclosed **'2025 Semi-Annual Report'**[6](index=6&type=chunk)